Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.